Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis ; volume:11 ; number:1 ; day:10 ; month:12 ; year:2022 ; pages:1-30 ; date:12.2022
Systematic Reviews ; 11, Heft 1 (10.12.2022), 1-30, 12.2022
- Urheber
-
Yuan, Ye
Liu, Xumei
Cai, Yi
Li, Wenyuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-022-02134-9
- URN
-
urn:nbn:de:101:1-2023022021253553677606
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yuan, Ye
- Liu, Xumei
- Cai, Yi
- Li, Wenyuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
Einsatz von Pertuzumab und Trastuzumab im Vergleich zu Trastuzumab-Monotherapie beim HER2-positiven Mammakarzinom - eine multizentrische Kohortenstudie
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
Einsatz von Pertuzumab und Trastuzumab im Vergleich zu Trastuzumab-Monotherapie beim HER2-positiven Mammakarzinom - eine multizentrische Kohortenstudie
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre